Rural MOUD Telemedicine in Primary Care Phase 1

Completed

• Conditions: Opioid-use Disorder
• Interventions: Other: Integration of telemedicine for MOUD in primary care

• Registration Number: NCT04418453
• Lead Sponsor: University of California, Los Angeles

Brief Summary

The feasibility study (Phase 1) will examine the implementation of telemedicine (TM) in six rural clinics in two states/regions with varying levels of OBOT capacity.

Detailed Description

The dramatic increases in opioid overdose deaths across the nation, particularly in rural areas, call for a rapid expansion of access to medication treatment for opioid use disorder (MOUD).There is a need to study effective ways to expand treatment access and improve retention on MOUD in rural areas highly impacted by OUD. Telemedicine (TM) for MOUD offers an alternative or supplementary approach to delivering MOUD that may be suitable for rural clinics and patients with OUD.

The objectives of the feasibility study are to study ways of incorporating TM into primary care clinics and to evaluate the associated outcomes, based on EHRs from the clinics and the TM vendor (i.e., patient days on MOUD) and participant surveys (e.g., opioid use). Additional outcomes of the feasibility study are feasibility and acceptability assessed from the perspectives of providers and participants via focus groups. A patient registry will be established in each clinic to track patients with OUD diagnoses, and those in the registry will be provided the opportunity to consent for sharing identified EHRs and participating in the follow-up surveys.

Study Timeline

• Study First Submitted: 2020-05-21
• Study Start: 2020-06-01
• Study First Submitted QC: 2020-06-03
• Study First Posted: 2020-06-05
• Primary Completion: 2021-07-29
• Study Completion: 2021-11-05
• Status Verified: 2023-05
• Last Update Submitted: 2023-05-09
• Last Update Posted: 2023-05-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 36762

Inclusion Criteria

• Aged 18-80 years old, inclusive, at the time of the qualifying visit
• with OUD diagnosis
• At least 1 visit to the participating clinics from 9 months before and 6 months after the date of intervention implementation

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Integration of telemedicine in primary care settings for MOUD	Integration of telemedicine for MOUD in primary care	Primary care providers may refer OUD patients to receive telemedicine for MOUD

Primary Outcome Measures

Name	Time	Method
Patient days on MOUD from Electronic Health Records (EHR)	9 months	Number of days patients receive MOUD based on EHR data

Secondary Outcome Measures

Name	Time	Method
Number of OUD patients initiating/receiving MOUD	9 months	Number of OUD patients initiating/receiving MOUD

Trial Locations

Locations (6)

Syringa Hospital and Clinics; 🇺🇸 Grangeville, Idaho, United States

Penobscot Community Health Care; 🇺🇸 Winterport, Maine, United States

St. Mary's Hospital and Clinics; 🇺🇸 Cottonwood, Idaho, United States

Ferry County Health; 🇺🇸 Republic, Washington, United States

Providence Northeast Washington Medical Group; 🇺🇸 Colville, Washington, United States

Hometown Health Center; 🇺🇸 Dexter, Maine, United States